Neurology Central

Cannabidiol may reduce seizures in children with Dravet syndrome

Cannabidiol has been found to reduce seizures by approximately half in children with Dravet syndrome in a recent Phase III study. The study will be presented at the American Academy of Neurology’s 71st Annual Meeting (PA, USA, 4–10 May 2019).

“It’s exciting to be able to offer another alternative for children with this debilitating form of epilepsy and their families,” explained Ian Miller, Nicklaus Children’s Hospital (FL, USA). “The children in this study had already tried an average of four epilepsy drugs with no success and at the time were taking an average of three additional drugs, so to have this measure of success with cannabidiol is a major victory.”

The study included 199 children with an average age of 9 years, who were divided into three groups. One group received a placebo drug, the second group

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.